Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Precision Biosciences (DTIL) Consolidated Net Income (2018 - 2025)

Historic Consolidated Net Income for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to -$20.0 million.

  • Precision Biosciences' Consolidated Net Income fell 118.37% to -$20.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.0 million, marking a year-over-year decrease of 2935479.45%. This contributed to the annual value of -$18.8 million for FY2023, which is 5147.7% up from last year.
  • As of Q3 2025, Precision Biosciences' Consolidated Net Income stood at -$20.0 million, which was down 118.37% from -$21.1 million recorded in Q2 2025.
  • In the past 5 years, Precision Biosciences' Consolidated Net Income registered a high of $25.4 million during Q2 2024, and its lowest value of -$30.7 million during Q4 2021.
  • Over the past 5 years, Precision Biosciences' median Consolidated Net Income value was -$11.6 million (recorded in 2021), while the average stood at -$11.3 million.
  • Examining YoY changes over the last 5 years, Precision Biosciences' Consolidated Net Income showed a top increase of 38707.38% in 2024 and a maximum decrease of 73166.37% in 2024.
  • Over the past 5 years, Precision Biosciences' Consolidated Net Income (Quarter) stood at -$30.7 million in 2021, then soared by 70.5% to -$9.1 million in 2022, then skyrocketed by 68.49% to -$2.9 million in 2023, then crashed by 731.66% to -$23.7 million in 2024, then grew by 15.76% to -$20.0 million in 2025.
  • Its Consolidated Net Income was -$20.0 million in Q3 2025, compared to -$21.1 million in Q2 2025 and -$21.1 million in Q1 2025.